InterVene: Funding, Investors & Team (Oct 2026)
InterVene Inc. is a medical device company developing interventional technologies to treat and prevent chronic venous insufficiency (CVI) with a focus on deep veins and severe, complex venous diseases. The company’s Recana™ thrombectomy catheter system is designed to recanalize chronically obstructed deep veins and to facilitate treatment of in-stent restenosis, particularly in cases where recanalization options are limited or long-term stent maintenance is required. Recana is an investigational device limited by Federal (US) law to investigational use. Based in Redwood City, California, InterVene has assembled an exemplary team of employees, investors, advisors and board members, all possessing extensive vascular and venous interventional market experience.
InterVene has raised $13.0M across 1 funding round on record, the most recent a Series A of $13.0M announced in Oct 2024.
That round is above the $5.0M median round size for Health Care companies tracked on FundedIQ over the last two years.
InterVene Company Profile and Key Stats
Latest funding round on record: Oct 2024.
InterVene Funding Rounds
InterVene Founders and Leadership Team
No contact details are on record for this team yet.
InterVene Funding Compared to Other Health Care Startups
InterVene's latest round of $13.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like InterVene in Health Care and South San Francisco
Companies Similar to InterVene
Treso operates as a financial software provider that develops an integrated financial operating system…
Optain produces medical tools and technology with the aim of providing healthcare access to everyone,…
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
InterVene Funding FAQs
What does InterVene do?
InterVene Inc. is a medical device company developing interventional technologies to treat and prevent chronic venous insufficiency (CVI) with a focus on deep veins and severe, complex venous diseases. The company’s Recana™ thrombectomy catheter system is designed to recanalize chronically obstructed deep veins and to facilitate treatment of in-stent restenosis, particularly in cases where recanalization options are limited or long-term stent maintenance is required. Recana is an investigational device limited by Federal (US) law to investigational use. Based in Redwood City, California, InterVene has assembled an exemplary team of employees, investors, advisors and board members, all possessing extensive vascular and venous interventional market experience.
How much funding has InterVene raised?
InterVene has raised $13.0M across 1 round on record. The most recent is a Series A of $13.0M announced in Oct 2024.
When did InterVene last raise funding?
InterVene's most recent funding round on record is a Series A of $13.0M, announced in Oct 2024.
Who founded InterVene?
FundedIQ lists Aaron Mccloud (Founder) at InterVene.
Where is InterVene headquartered?
InterVene is based in South San Francisco, California, United States.
How many employees does InterVene have?
InterVene is in the 1-10 employee band.
How does InterVene's funding compare to other Health Care startups?
InterVene's latest round of $13.0M is above the $5.0M median round size for Health Care companies on FundedIQ across 3,660 tracked companies over the last two years.
About FundedIQ's InterVene Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for InterVene is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.